Novel Blood Pressure Medications Exploring the Potential of Dual-Acting RNA-Based Therapies
The Promise of Ultra-Long-Acting Therapies for Adherence
The holy grail of chronic disease management is to reduce the treatment burden to the absolute minimum, ideally to one administration per year. The high blood pressure therapeutic landscape is moving closer to this reality with the advancement of ultra-long-acting subcutaneous injectables and even small, biodegradable implants. These...